Eris Lifesciences Limited

Business news, market intelligence, and global industry analysis.

The Latest

Representative image: Oracle (NYSE: ORCL) stock jumps 13% on record cloud earnings and multicloud momentum

Oracle (NYSE: ORCL) rallies 10% after earnings as $553bn RPO signals AI infrastructure dominance

Agentic AI arms race: Zendesk and Forethought challenge Salesforce Agentforce and ServiceNow Moveworks

Representative image of a cloud data center environment illustrating enterprise legacy system migration to Microsoft Azure, reflecting Kyndryl’s Cloud Uplift expansion in Canada to modernize mission-critical workloads while keeping data within national datacentre regions.

The quiet legacy cloud migration battle is heating up and Kyndryl just made a strategic move in Canada

Representative image of liquid-cooled AI server hardware inside a hyperscale data center, illustrating the type of direct-to-chip cooling infrastructure being developed through the Flex and Broadcom collaboration to support next-generation AI XPUs and high-density artificial intelligence workloads.

AI chips are overheating. Can Flex and Broadcom fix the cooling crisis?

Eris Lifesciences acquires nine Glenmark Pharmaceuticals dermatology brands in INR340.48 crore deal

Eris Lifesciences’ ₹340.48 crore purchase of nine Glenmark Pharmaceuticals dermatology brands reshapes India’s pharma market. See how it impacts strategy and growth.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

January 18, 2023